NutraLife Biosciences Inc logo

NutraLife Biosciences Inc

$ 0.07 0 (0%) 03:17 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 12.29M
Enterprise V:
$ 15.27M
Volume:
-
Avg Vol (2M):
34.18K
Volume:
-
Market Cap $:
12.29M
PE Ratio:
At Loss
Avg Vol (2-Month):
34.18K
Enterprise Value $:
15.27M
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

NutraLife Biosciences Inc
NAICS : 325411 SIC : 2834
6601 Lyons Road, Suite L-6, Coconut Creek, FL, USA, 33073
Description
NutraLife BioSciences Inc is engaged in the development, manufacturing and distribution of nutritional and dietary nutritional supplement products. The company is a branded and private label developer, manufacturer and distributor of a wide range of nutraceutical, wellness, and CBD products. It's private-label ingestible and skincare products include CBD-infused oral sprays, tinctures, pet drops, pain balms, and face creams. Its CBD products are derived from the seeds and mature stalks of the Cannabis Sativa plant which includes all parts and varieties of the cannabis sativa plant also known as hemp, which contain a tetrahydrocannabinol concentration.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.02
Equity-to-Asset -0.22
Debt-to-Equity -2.44
Debt-to-EBITDA -1.52
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -13.35
Distress
Grey
Safe
Beneish M-Score 150.11
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 60.01
9-Day RSI 51.14
14-Day RSI 48.14
6-1 Month Momentum % 12.5
12-1 Month Momentum % -10

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.1
Quick Ratio 0.02
Cash Ratio 0.01
Days Inventory 303.93
Days Sales Outstanding 44.82
Days Payable 146.77

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.8

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 0.18
Operating Margin % -451.58
Net Margin % -773.68
ROA % -91.38
ROIC % -35.77
ROC (Joel Greenblatt) % -82.35
ROCE % -422.11

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 35
EV-to-EBIT -6.28
EV-to-EBITDA -7.33
EV-to-Revenue 25.62
EV-to-FCF -12.47
Earnings Yield (Greenblatt) % -15.92

Financials

NLBS's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with OTCPK:NLBS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.57
EPS (TTM) ($) -0.044
Beta -1.27
Volatility % 48.62
14-Day RSI 48.14
14-Day ATR ($) 0.008259
20-Day SMA ($) 0.070789
12-1 Month Momentum % -10
52-Week Range ($) 0.0431 - 0.1225
Shares Outstanding (Mil) 175.6

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

NutraLife Biosciences Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More